logo

Dr Reddy's Laboratories Ltd. (RDY)



Trade RDY now with
  Date
  Headline
2/22/2021 1:16:45 AM Dr. Reddy's Labs Announces Launch Of Lansoprazole DR Orally Disintegrating Tablets In U.S.
2/19/2021 5:56:19 AM Dr. Reddy's Initiates Process With Drugs Controller General Of India For Emergency Use Authorization Of Sputnik V
2/18/2021 2:20:29 AM Dr. Reddy's Labs Launches Fluphenazine Hydrochloride Tablets, USP In U.S. Market
2/17/2021 5:23:52 AM Dr. Reddy's Laboratories Launches Capecitabine Tablets, USP In The U.S. Market
2/2/2021 4:24:48 AM Dr. Reddy's Laboratories Unveils Vigabatrin Tablets, USP In The U.S. Market
1/29/2021 4:42:00 AM Dr. Reddy's Q3 EPS $0.02 Vs Loss $0.47 Last Year
1/27/2021 5:09:42 AM Dr. Reddy's And GRA Announce Termination Of Avigan Study
1/11/2021 5:05:18 AM Dr. Reddy's Laboratories Unveils Febuxostat Tablets In The U.S. Market
12/22/2020 1:21:41 AM Dr. Reddy's, Global Response Aid, Appili Therapeutics Announce Filing Of Application For REEQONUS Tablets
12/22/2020 1:17:31 AM Dr. Reddy's, Appili Therapeutics File Application For REEQONUS Tablets For COVID-19 Under Health Canada's Interim Order